JPRN-jRCT2080225290
Completed
Phase 1
A Phase I, Open label, Multi-Center Clinical Pharmacological Study of nemolizumab with a Single-dose in Japanese Atopic Dermatitis Patients with moderate to severe pruritus
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Atopic dermatitis with pruritus who are inadequately controlled by existing therapies
- Sponsor
- Maruho Co., Ltd.
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Atopic dermatitis with moderate or severe pururitus Patients
Exclusion Criteria
- •\-Patients with Hepatitis B virus or hepatitis C virus infection
- •\-Patients with Evidence of tuberculosis (TB) infection
- •\-Patients with immune deficiency
- •\-Pregnant or lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A phase I, multi-center, open-label, drug-drug interaction study to assess the effect of the CYP1A2 inhibitor, fluvoxamine, on TKI258 (dovitinib) pharmacokinetics in patients with advanced solid tumors.advanced cancersolid tumors10027655NL-OMON39285ovartis12
Completed
Not Applicable
A Phase 1, Open-Label, Multicenter, Drug-Drug Interaction Study of TAK-788 and Midazolam, a Sensitive CYP3A Substrate, in Patients With Advanced Non*Small Cell Lung CancerNL-OMON49519Millenium Pharmaceuticals6
Active, not recruiting
Phase 1
A study to evaluate the safety, processing by the body and response of the body to tenecteplase in adults with acute ischemic strokeISRCTN13376195Roche (United States)20
Recruiting
Phase 4
A multicentre study of the dose concentration response of febuxostat in patients with chronic gout.ACTRN12616000959471St Vincent's Hospital120
Active, not recruiting
Phase 1
A study to evaluate the effect of Levonorgestrel-Emergency Contraception Tablet on Ovulation Inhibition in groups with a BMI that ranges underweight to obeseOvulationMedDRA version: 20.0Level: PTClassification code 10036251Term: Post coital contraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10033313Term: Ovulation inhibitedSystem Organ Class: 100000004860Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]EUCTR2019-001143-43-GBGedeon Richter Plc.520